propranolol has been researched along with medroxalol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cheng, HC; Gibson, JP; Sells, DM; Yuh, L | 1 |
| Cheng, HC; Reavis, OK; Woodward, JK | 1 |
| Hancock, AA | 1 |
4 other study(ies) available for propranolol and medroxalol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Induction of uterine leiomyomas in mice by medroxalol and prevention by propranolol.
Topics: Animals; Dose-Response Relationship, Drug; Ethanolamines; Female; Leiomyoma; Mice; Muscle, Smooth; Propranolol; Uterine Neoplasms | 1987 |
Effect of RMI 81968, a combined alpha- and beta-adrenergic receptor blocking agent, on histamine-induced bronchoconstriction in the dog.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Airway Resistance; Animals; Bronchi; Dogs; Drug Interactions; Ethanolamines; Female; Histamine; Histamine H1 Antagonists; Male; Propranolol | 1980 |
Analysis of the hypotensive effects of medroxalol and its enantiomers, MDL 17,330A and MDL 17,331A.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Dogs; Ethanolamines; Male; Norepinephrine; Phenylephrine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Neurotransmitter; Yohimbine | 1984 |